Pharmaceutical Industry Blog

Inolimomab is a monoclonal antibody designed to treat steroid-refractory acute graft-versus-host disease (GVHD). This innovative therapy...

Apamistamab is a targeted radioimmunotherapy designed to treat various blood cancers, including acute myeloid leukemia (AML) and relapsed...

Elranatamab is a bispecific antibody designed to treat multiple myeloma, a type of blood cancer that affects plasma cells in the bone...

Felzartamab is a monoclonal antibody designed to treat autoimmune diseases by targeting CD38, a protein found on the surface of certain...

Naratuximab emtansine, also known as Debio 1562 or IMGN529, is an antibody-drug conjugate designed to treat relapsed or refractory...

Erenumab is an innovative treatment designed to prevent migraines in adults. This medication is part of a new class of drugs known as...